Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 4.33345 | 70 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 4.31529 | 69 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 4.31196 | 69 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 4.18677 | 68 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 4.28506 | 69 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 4.52279 | 72 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 4.37547 | 70 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 4.32256 | 70 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 4.10235 | 67 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 4.30342 | 69 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 4.29397 | 69 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 4.29774 | 69 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 4.30809 | 70 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 4.29778 | 70 |